Adsorption of octylamine on titanium dioxide
Source abstract
Abstract
Abstract Processes of adsorption and desorption of a model active substance (octylamine) on the surface of unmodified titanium dioxide (E 171) have been performed. The effects of concentration of octylamine and time of the process on the character of adsorption have been studied and the efficiency of the adsorption/desorption has been determined. The samples obtained have been studied by X-ray diffraction. The nitrogen adsorption/desorption isotherms, particle size distribution and absorption capacities of water, dibutyl phthalate and paraffin oil have been determined. The efficiency of octylamine adsorption on the surface of the titanium dioxide has been found positively correlated with the concentration of octylamine in the initial solution. The desorption of octylamine has decreased with increasing concentration of this compound adsorbed. For octylamine in low concentrations the physical adsorption has been found to dominate, which is desirable when using TiO 2 in the production of pharmaceuticals.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Analytical Chemistry and Chromatography · Chemical Synthesis and Reactions · Innovative Microfluidic and Catalytic Techniques Innovation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (23)
Show source-provided references
1. Xiabo · Chem. Rev. · 2007 · 107 · 289
2. Benjakul · Int. J. Food Sci. Technol. · 2004 · 39 · 77310.1111/j.1365-2621.2004.00843.x ↗
3. G.E. Uzunian, W.J. Sullivan, Patent – PCT/US2002/018680.
4. Loden · J. Pharm. Sci. · 2005 · 94 · 78110.1002/jps.20295 ↗
5. Starzyk · 2007
6. Baran · Rynek Chem. · 2006 · 3 · 25
7. Rowe · 2006
8. R.H. Muller, G.E. Hildebrand, Technologia nowoczesnych postaci leku, Wydawnictwo Lekarskie PZWL, Warszawa, 2003.
9. Bechard · Int. J. Pharm. · 1992 · 87 · 13310.1016/0378-5173(92)90236-U ↗
10. A. Marra, A. Dondoni, C.A. Bignozzi, R. Canevotti, G.P. Negrisoli, V. Dissette, Patent – PCT/EP2006/003348.
11. Hirasawa · Chem. Pharm. Bull. · 2004 · 52 · 224410.1248/cpb.52.244 ↗
12. Heikkil · Drug Deliv. · 2007 · 14 · 33710.1080/10717540601098823 ↗
13. Tilak · Drug Dev. Ind. Pharm. · 2000 · 26 · 102510.1081/DDC-100100266 ↗
14. Hashida · Chem. Pharm. Bull. · 2005 · 53 · 887110.1248/cpb.53.871 ↗
15. Hu · Eur. J. Pharm. Biopharm. · 2008 · 70 · 74910.1016/j.ejpb.2008.06.015 ↗
16. Kajihara · Chem. Pharm. Bull. · 2003 · 51 · 111
17. Suttiruengwong · Pharm. Dev. Technol. · 2006 · 11 · 5510.1080/10837450500463919 ↗
18. Shen · Chem. Pharm. Bull. · 2007 · 55 · 7985
19. Dressman · 2005
20. Wu · J. Control. Release · 2007 · 119 · 21510.1016/j.jconrel.2007.03.001 ↗
21. Steele · Drug Dev. Ind. Pharm. · 2003 · 29 · 47510.1081/DDC-120018382 ↗
22. The European Pharmacopoeia 6.0, Council of Europe, Strasbourg, 2007.
23. Jesionowski · Colloids Surf. A · 2002 · 207 · 4910.1016/S0927-7757(02)00137-1 ↗